BCATc inhibitor 2 ameliorated mitochondrial dysfunction and apoptosis in oleic acid-induced non-alcoholic fatty liver disease model.

Lu, Zhuo; Sun, Gui-Feng; Pan, Xiao-An; Qu, Xin-Hui; Yang, Ping; Chen, Zhi-Ping; Han, Xiao-Jian; Wang, Tao

Lu, Zhuo; Sun, Gui-Feng; Pan, Xiao-An; Qu, Xin-Hui; Yang, Ping; Chen, Zhi-Ping; Han, Xiao-Jian; Wang, Tao.

Affiliation

Lu Z; Institute of Geriatrics, Jiangxi Provincial People's Hospital and The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Sun GF; Department of Thoracic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Pan XA; Department of Pharmacology, School of Pharmaceutical Science, Nanchang University, Nanchang, China.
Qu XH; Department of Pharmacology, School of Pharmaceutical Science, Nanchang University, Nanchang, China.
Yang P; Institute of Geriatrics, Jiangxi Provincial People's Hospital and The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Chen ZP; Department of Neurology, Jiangxi Provincial People's Hospital and The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Han XJ; Department of Neurology, Jiangxi Provincial People's Hospital and The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Wang T; Department of Critical Care Medicine, Jiangxi Provincial People's Hospital and The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.

Front Pharmacol ; 13: 1025551, 2022.

Article in En | MEDLINE | ID: mdl-36386234

Key words

BCTAc inhibitor 2; NAFLD; apoptosis; mitochondrial dysfunction; oxidative stress

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: Country of publication:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google